SLC2A1 and Hyperinsulinemia: In the context of hyperinsulinemia easily accompanying EC patients, some studies have demonstrated that metformin could suppress the proliferation of ECCs by changing GLUT1-related glucose metabolism and inhibiting the PI3K/AKT/mTOR signaling pathway (174).